Ocular Inflammation Treatment Market
Ocular Inflammation Treatment Market (Treatment Type - Corticosteroids, Antibiotics, Monoclonal Antibodies, Immunosuppressant, Cycloplegic Agents, Antivirals, Antifungal and Analgesics; Disease Type - Anterior Uveitis, Posterior Uveitis, Panuveitis, Intermediate Uveitis, and Episcleritis/Scleritis; Mode of Administration - Topical, Injectables, Oral, and Others; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Drug Stores) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017-2026
Press Release :
Global Ocular Inflammation Treatment Market: Snapshot
Rising Environmental Conditions to Boost the Growth of the Market
The world is facing a major environmental crisis due to emission of harmful gases from factories and other industries. These environmental conditions can lead to ocular inflammation which is also known as uveitis. With the help of developing technologies and improving drug delivery systems, several new treatments have made their way into the mainstream healthcare market. Owing to these developments the global ocular inflammation treatment market is projected to witness a substantial growth during the tenure of 2017 to 2026. Moreover, improving healthcare infrastructure of various developing countries is also a major factor that is boosting the growth of ocular inflammation treatment market during the estimated time frame.
The report provides an in-depth analysis of the global ocular inflammation treatment market fort the forecast of 2017 to 2025. To provide actionable insights to the readers, the report analyses facets such as drivers, challenges, and trends of the global ocular inflammation treatment market. With the help of these insights, the players can get thorough understanding of the dynamics of global ocular inflammation treatment market. The report also states that the global ocular inflammation treatment market shall witness a 6.9% CAGR during the tenure of 2017 to 2026 and shall reach to the value of US$ 1 Bn by the end of the forecast period.
The global ocular inflammation treatment market is highly competitive and has a massively fragmented scenario. The landscape is the result of greater opportunities for the players as there is a major demand for treatment and solutions in hospitals and pharmaceutical institutes. However, due to high degree of competition, the new players are unable to enter the ocular inflammation treatment market.
To tackle this situation, the new players are joining hands with some of the prominent players of the ocular inflammation treatment market. This strategy shall help the new players to acquire essential resource that can help achieve sustainability in the ocular inflammation treatment market.
On the other hand, the established players are using acquisition as their resort to maintain their stronghold in the global ocular inflammation treatment market. The strategy helps the players to gain access to the technology, production and distribution facilities so that they can reach to a greater audience. Also with the help of this strategy the established players can gain a significant edge over the rivals in the ocular inflammation treatment market during the tenure of 2017 to 2026.
Global Ocular Inflammation Treatment Market: Trends and Drivers
Rising Cases of Uveitis to Boost the Growth of the Market
Due to growing pollutions and harmful carbon emission from vehicles, factories, and other industries has led to a massive increase in the cases of uveitis. Under this disease, the middle layer of the eye gets swollen and develops a blood clot in due to which there is irresistible itching and irritation in the eyes. Though this disease is not directly transferred to another person, but with rising pollution it can spread to hundreds of people. Owing to this urgency, there is a major demand for an effective ocular inflammation treatment in hospitals and other medical institutes. Owing to this demand the global ocular inflammation treatment market is expected to witness an exponential growth during the tenure of 2017 to 2026.
Moreover due to global pandemic of COVID-19, the global ocular inflammation treatment market is also expected to witness a substantial growth during the estimated time frame. The virus enters human body through mouth, nose, and eyes. Owing to this protection of eyes is highly crucial. This as a result helps the global ocular inflammation treatment market to witness a substantial growth during the tenure of 2017 to 2025, says the report by Transparency Market Research.
Global Ocular Inflammation Treatment Market: Segmentation
Anterior Uveitis Treatment to Hold Largest Share in the Global Ocular Inflammation Treatment Market
The anterior uveitis treatment is expected to hold the largest share in the global ocular inflammation treatment market. The dominance of the segment is attributed to the growing cases of the uveitis disease across the globe. The segment is projected to account for more than US$ 530 Mn during the tenure of 2017 to 2026. The major people that are affected from this disease are middle aged and young people. Since the number of this generic of the people is higher, the number of affected people is also increasing these days. Owing to this growth the anterior uveitis is expected to hold the largest share in the global ocular inflammation treatment market during the tenure of 2017 to 2026.
Corticosteroids to Hold Second Highest Market Share
The report findings reveal a growing demand for corticosteroids for treatment of ocular inflammation. In 2017, over US$ 150 million worth of corticosteroids were sold in the global ocular inflammation treatment market. The effectiveness of corticosteroid eye drops in treating uveitis by suppressing inflammations instantly will be observed as a key driver for its growing demand in the coming years. Treating ocular inflammations through administration of monoclonal antibodies is also expected to witness surging demand, reflecting a high value CAGR of 8.1% over the forecast period.
Few Competitors of the Global Ocular Inflammation Treatment Market
- Valeant Pharmaceuticals International, Inc
- Eyegate Pharmaceuticals, Inc
- Novartis AG
- Abbvie, Inc.,
- Allergan Plc.,
- pSivida Corporation
- Pfizer, Inc.
- Cipla Ltd.
Ocular Inflammation Treatment: Global Market Overview
Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration. The global market for ocular inflammation treatment is expected to grow sharply in the coming years. Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.
Transparency Market Research’s latest report offers key insights on how the global ocular inflammation treatment market will expand during the forecast period, 2017-2026. This report sheds qualitative information and forecasted market size evaluations on the global ocular inflammation treatment market expansion for the assessment period.
Key Offerings of the Report
There are a range of advantages of availing this TMR study, particularly for companies interested in expanding their stakes in the global ocular inflammation treatment market. A constant dialogue industry leaders, opinion makers, trade analysts and market participants has generated volumes of data, which has been analyzed across multiple parameters during the development of this study.
An all-embracive research methodology employed for developing accurate forecast on the global ocular inflammation treatment market offers insights in terms of:
- changing stance of the FDA on uveitis drugs
- causative factors triggering the incidence of eye inflammations across the globe
- initiatives of governments in promoting awareness through uveitis programs
- contribution of medical research organizations towards developing new therapies that extend the use of ocular inflammation drugs
- addressing the instances that cite ineffectiveness of particular ocular inflammation treatments
From pricing and cost structure to supply chain characteristics, the report supplying objective information on how the global ocular inflammation treatment market will evolve in the coming years. This information has been validated through authentic quality checks and data screening processes. New opportunities for market growth have been revealed, and a slew of first-hand information makes this report a valuable document for companies aiming to expand their business in the ocular inflammation treatment market.
Assessing Details on Key Market Stakeholders
The presence of pharmaceutical industry leaders is fairly consolidated in the global market for ocular inflammation treatments. The report has profiled these market players extensively, tracking their growth till data and tracing their strategic developments in the recent past. Unbiased analysis of such information has generated insights on how a particular pharmaceutical company will take steps towards expanding its stake in the local as well as global ocular inflammation treatment markets.
The current stance of the FDA towards clearing the uveitis pipelines has also been addressed while measuring the potential of companies in contributing immensely towards the future of global ocular inflammation treatment market. Information on their investments portfolio, R&D undertakings and mergers & acquisitions has been summarized to extend the understanding of companies in terms of competitor analysis. The overall scope of this report is to ensure that key companies in the global ocular inflammation treatment market take informed steps towards future market direction.
Global Ocular Inflammation Treatment Market: Segmental Breakdown
Mode of Administration
(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)